Cargando…
CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
Rectal cancer patients with a complete response after neoadjuvant therapy can be monitored with a watch-and-wait strategy. However, regrowth rates indicate that identification of patients with a pathological complete response (pCR) remains challenging. Targeted near-infrared fluorescence endoscopy i...
Autores principales: | Linders, Daan, Deken, Marion, van der Valk, Maxime, Tummers, Willemieke, Bhairosingh, Shadhvi, Schaap, Dennis, van Lijnschoten, Gesina, Zonoobi, Elham, Kuppen, Peter, van de Velde, Cornelis, Vahrmeijer, Alexander, Farina Sarasqueta, Arantza, Sier, Cornelis, Hilling, Denise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002064/ https://www.ncbi.nlm.nih.gov/pubmed/33799475 http://dx.doi.org/10.3390/diagnostics11030516 |
Ejemplares similares
-
Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors
por: Baart, Victor M., et al.
Publicado: (2021) -
Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer
por: de Valk, Kim S., et al.
Publicado: (2020) -
Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
por: Tummers, Willemieke S., et al.
Publicado: (2017) -
Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018) -
Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer
por: de Muijnck, Cansu, et al.
Publicado: (2020)